Large-scale analyses of the prostate cancer (PCa) database have discovered a persistent difference between the death rate of Black patients and that of White patients. Additionally, there were variations in PCa therapy and prognosis among Black males of various ethnic backgrounds. For a study, researchers sought to identify the demographic variables associated with a treatment decision for definitive treatment of PCa in a single institution’s patient population of Black immigrants due to the heterogeneity of PCa-impacted communities and the unclear impact of patient immigration status on treatment outcomes.
From February 2019 to February 2020, they sent questionnaires to every patient at the Kings County Hospital Center’s urologic oncology clinic and used the electronic medical record to gather pertinent health data. Age, education, health insurance, work position, socioeconomic status, country of birth, and years spent in the United States (US) were the demographic data the study gathered.
The bulk of the 253 patients that were assessed was Black and foreign-born. Except for the number of years spent in the country, there were no notable demographic differences between patients who were US citizens and those who were not. Patients with less than 10 years of US residence in the intermediate risk group opted for surgery (90.9% vs. 50.0%, P=0.036). On multivariate analysis, individuals who selected surgery were less likely to have been born in the United States than in African or Caribbean nations (OR = 0.054) and more likely to be older when diagnosed (odds ratio [OR] = 1.21).
In line with earlier research, they discovered that patients born in the United States were less likely to choose surgery than their overseas counterparts in our study of a predominately Black group. In addition, age at diagnosis and immigrant status were observed to impact Black males with intermediate-risk PCa regarding their final treatment option.